Citigroup’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-212,510
| Closed | -$4.13M | – | 5221 |
|
|
2018
Q1 | $4.13M | Buy |
212,510
+175,616
| +476% | +$3.42M | ﹤0.01% | 1067 |
|
|
2017
Q4 | $614K | Buy |
36,894
+36,402
| +7,399% | +$606K | ﹤0.01% | 2232 |
|
|
2017
Q3 | $10K | Sell |
492
-1,051
| -68% | -$21.4K | ﹤0.01% | 4230 |
|
|
2017
Q2 | $25K | Sell |
1,543
-2,856
| -65% | -$46.3K | ﹤0.01% | 3871 |
|
|
2017
Q1 | $56K | Sell |
4,399
-157,146
| -97% | -$2M | ﹤0.01% | 3621 |
|
|
2016
Q4 | $2.14M | Buy |
161,545
+158,380
| +5,004% | +$2.1M | ﹤0.01% | 1784 |
|
|
2016
Q3 | $75K | Sell |
3,165
-30,817
| -91% | -$730K | ﹤0.01% | 3545 |
|
|
2016
Q2 | $980K | Sell |
33,982
-19,637
| -37% | -$566K | ﹤0.01% | 1694 |
|
|
2016
Q1 | $1.72M | Buy |
53,619
+49,375
| +1,163% | +$1.58M | ﹤0.01% | 1577 |
|
|
2015
Q4 | $181K | Sell |
4,244
-2,476
| -37% | -$106K | ﹤0.01% | 3138 |
|
|
2015
Q3 | $236K | Sell |
6,720
-2,029
| -23% | -$71.3K | ﹤0.01% | 2695 |
|
|
2015
Q2 | $402K | Sell |
8,749
-1,779
| -17% | -$81.7K | ﹤0.01% | 2308 |
|
|
2015
Q1 | $494K | Sell |
10,528
-12,684
| -55% | -$595K | ﹤0.01% | 2302 |
|
|
2014
Q4 | $735K | Buy |
23,212
+9,801
| +73% | +$310K | ﹤0.01% | 2076 |
|
|
2014
Q3 | $318K | Buy |
13,411
+3,978
| +42% | +$94.3K | ﹤0.01% | 2324 |
|
|
2014
Q2 | $283K | Sell |
9,433
-1,942
| -17% | -$58.3K | ﹤0.01% | 2321 |
|
|
2014
Q1 | $300K | Sell |
11,375
-26,270
| -70% | -$693K | ﹤0.01% | 2517 |
|
|
2013
Q4 | $947K | Buy |
37,645
+11,655
| +45% | +$293K | ﹤0.01% | 1889 |
|
|
2013
Q3 | $533K | Sell |
25,990
-6,630
| -20% | -$136K | ﹤0.01% | 1936 |
|
|
2013
Q2 | $650K | Buy |
+32,620
| New | +$650K | ﹤0.01% | 1870 |
|